the Production of vaccine against the coronavirus SARS-CoV-2 can begin in the near future. “Probably within four to six weeks,” – said the TV channel CNBC, a source in the White house. It is expected that by the beginning of 2021 pharmaceutical companies in the US will produce 300 million doses of the drug. Although not specified what kind of test now vaccines will be effective.
Meanwhile, Russia has completed clinical trials the world’s first vaccine against COVID-19. The effect of the drug was studied in Sechenovskiy University volunteers. Side effects the participants of the experiment were observed.
the Main question: how will be the long-term immune response obtained by vaccination. Previously, German scientists reported that after two months, the number of antibodies to the coronavirus in the blood of survivors is significantly reduced, especially those who suffered the disease without symptoms.
the Researchers are preparing a package of documents for registration of new vaccines in the health Ministry to expedite its output on the market. This can happen 2-4 August, said the Director of the National research centre of epidemiology and Microbiology named Gamalei Alexander Ginzburg. According to him, a vaccine against SARS-CoV-2 may act in civil circulation in mid-August.
